Chiesi Group receives the European marketing authorisation for Trimbow® (beclometasone dipropionate, formoterol fumarate, glycopyrronium) an extrafine formulation fixed triple combination therapy for the treatment of asthma
01 Febbraio 2021
Chiesi Headquarters: an innovative, sustainable and people-friendly “home”, the first building in its category to be certified “LEED Platinum” in Italy. A people-oriented project.
27 Gennaio 2021
“Infermieri, a viso aperto”, a photographic project bringing to light the faces and stories of those who help patients every day
14 Gennaio 2021
Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets
30 Novembre 2020
Chiesi Group receives Diversity Leaders Award 2021
19 Novembre 2020
Chiesi launches “The Art of Caring”, a journey in search of the link between Parma, officinal treatments and pharmaceutics
17 Novembre 2020
Maria Paola Chiesi received by the President of the Italian Republic for the 2020 Bellisario Award ceremony
15 Ottobre 2020
We ACT Day 2020: the third edition of Chiesi’s event for a sustainable future
24 Settembre 2020
Chiesi Farmaceutici President appointed Knight of the Légion d’Honneur
18 Settembre 2020
Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for Pulmonary Arterial Hypertension (PAH).
